Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Nuclear Medicine Année : 2023

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy

Dates et versions

hal-04393804 , version 1 (15-01-2024)

Identifiants

Citer

Clara Diaz Garcia-Prada, Léna Carmes, Salima Atis, Ali Parach, Alejandro Bertolet, et al.. Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy. Journal of Nuclear Medicine, 2023, 64 (12), pp.1956-1964. ⟨10.2967/jnumed.123.265418⟩. ⟨hal-04393804⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More